AbCellera jumps 22% on positive trial data
The antibody discovery company's shares rose sharply after it reported favourable clinical trial results.
Every report the desk has filed, searchable by full text, topic, format, symbol and date range.
The antibody discovery company's shares rose sharply after it reported favourable clinical trial results.